Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Glenn Goetgeluk

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
International Journal of Molecular Sciences|February 2, 2018
Nanobody Based Dual Specific CARsStijn De Munter, Joline Ingels, Glenn Goetgeluk, et al.
Oncoimmunology|March 3, 2020
T-cells with a single tumor antigen-specific T-cell receptor can be generated <i>in vitro</i> from clinically relevant stem cell sourcesSarah Bonte, Stijn De Munter, Glenn Goetgeluk, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 16, 2019
TCR Sequencing Reveals the Distinct Development of Fetal and Adult Human Vγ9Vδ2 T CellsMaria Papadopoulou, Paola Tieppo, Naomi McGovern, et al.
Oncoimmunology|August 9, 2021
<i>In vitro</i> OP9-DL1 co-culture and subsequent maturation in the presence of IL-21 generates tumor antigen-specific T cells with a favorable less-differentiated phenotype and enhanced functionalitySarah Bonte, Stijn de Munter, Lore Billiet, et al.
Haematologica|April 26, 2012
RHAMM/HMMR (CD168) is not an ideal target antigen for immunotherapy of acute myeloid leukemiaSylvia Snauwaert, Stijn Vanhee, Glenn Goetgeluk, et al.
Oncoimmunology|April 14, 2017
Antigen receptor-redirected T cells derived from hematopoietic precursor cells lack expression of the endogenous TCR/CD3 receptor and exhibit specific antitumor capacitiesYasmine Van Caeneghem, Stijn De Munter, Paola Tieppo, et al.
International Journal of Molecular Sciences|November 25, 2020
Human Thymic CD10<sup>+</sup> PD-1<sup>+</sup> Intraepithelial Lymphocyte Precursors Acquire Interleukin-15 Responsiveness at the CD1a<sup>-</sup> CD95<sup>+</sup> CD28<sup>-</sup> CCR7<sup>-</sup> Developmental StageLore Billiet, Glenn Goetgeluk, Sarah Bonte, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 21, 2023
Delivery of macromolecules in unstimulated T cells by photoporation with polydopamine nanoparticlesDominika Berdecka, Aranit Harizaj, Ilia Goemaere, et al.
The Journal of Experimental Medicine|December 10, 2019
The human fetal thymus generates invariant effector γδ T cellsPaola Tieppo, Maria Papadopoulou, Deborah Gatti, et al.
Nano-Micro Letters|June 17, 2021
Intracellular Delivery of mRNA in Adherent and Suspension Cells by Vapor Nanobubble PhotoporationLaurens Raes, Stephan Stremersch, Juan C Fraire, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
International Journal of Molecular Sciences|February 2, 2018
Nanobody Based Dual Specific CARsStijn De Munter, Joline Ingels, Glenn Goetgeluk, et al.
Oncoimmunology|March 3, 2020
T-cells with a single tumor antigen-specific T-cell receptor can be generated <i>in vitro</i> from clinically relevant stem cell sourcesSarah Bonte, Stijn De Munter, Glenn Goetgeluk, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 16, 2019
TCR Sequencing Reveals the Distinct Development of Fetal and Adult Human Vγ9Vδ2 T CellsMaria Papadopoulou, Paola Tieppo, Naomi McGovern, et al.
Oncoimmunology|August 9, 2021
<i>In vitro</i> OP9-DL1 co-culture and subsequent maturation in the presence of IL-21 generates tumor antigen-specific T cells with a favorable less-differentiated phenotype and enhanced functionalitySarah Bonte, Stijn de Munter, Lore Billiet, et al.
Haematologica|April 26, 2012
RHAMM/HMMR (CD168) is not an ideal target antigen for immunotherapy of acute myeloid leukemiaSylvia Snauwaert, Stijn Vanhee, Glenn Goetgeluk, et al.
Oncoimmunology|April 14, 2017
Antigen receptor-redirected T cells derived from hematopoietic precursor cells lack expression of the endogenous TCR/CD3 receptor and exhibit specific antitumor capacitiesYasmine Van Caeneghem, Stijn De Munter, Paola Tieppo, et al.
International Journal of Molecular Sciences|November 25, 2020
Human Thymic CD10<sup>+</sup> PD-1<sup>+</sup> Intraepithelial Lymphocyte Precursors Acquire Interleukin-15 Responsiveness at the CD1a<sup>-</sup> CD95<sup>+</sup> CD28<sup>-</sup> CCR7<sup>-</sup> Developmental StageLore Billiet, Glenn Goetgeluk, Sarah Bonte, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 21, 2023
Delivery of macromolecules in unstimulated T cells by photoporation with polydopamine nanoparticlesDominika Berdecka, Aranit Harizaj, Ilia Goemaere, et al.
The Journal of Experimental Medicine|December 10, 2019
The human fetal thymus generates invariant effector γδ T cellsPaola Tieppo, Maria Papadopoulou, Deborah Gatti, et al.
Nano-Micro Letters|June 17, 2021
Intracellular Delivery of mRNA in Adherent and Suspension Cells by Vapor Nanobubble PhotoporationLaurens Raes, Stephan Stremersch, Juan C Fraire, et al.
Pageof 3